| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |